1. Home
  2. BEAM vs AEO Comparison

BEAM vs AEO Comparison

Compare BEAM & AEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

N/A

Current Price

$23.08

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Logo American Eagle Outfitters Inc.

AEO

American Eagle Outfitters Inc.

N/A

Current Price

$21.84

Market Cap

3.2B

ML Signal

N/A

Company Overview

Basic Information
Metric
BEAM
AEO
Founded
2017
1977
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.2B
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
BEAM
AEO
Price
$23.08
$21.84
Analyst Decision
Strong Buy
Hold
Analyst Count
15
14
Target Price
★ $49.85
$19.20
AVG Volume (30 Days)
1.8M
★ 4.1M
Earning Date
11-03-2026
12-01-2026
Dividend Yield
N/A
★ 2.31%
EPS Growth
★ 82.31
N/A
EPS
N/A
★ 0.92
Revenue
$24,000.00
★ $5,547,236,000.00
Revenue This Year
N/A
$5.60
Revenue Next Year
N/A
$3.62
P/E Ratio
★ N/A
$23.49
Revenue Growth
★ 33.33
4.10
52 Week Low
$20.23
$14.10
52 Week High
$38.26
$28.46

Technical Indicators

Market Signals
Indicator
BEAM
AEO
Relative Strength Index (RSI) 40.33 67.53
Support Level $22.65 $16.04
Resistance Level $28.19 $26.05
Average True Range (ATR) 1.92 0.87
MACD -0.33 0.15
Stochastic Oscillator 0.07 88.09

Price Performance

Historical Comparison
BEAM
AEO

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

About AEO American Eagle Outfitters Inc.

American Eagle Outfitters Inc is a specialty retailer. The company is engaged in the retail of apparel and accessories with company stores in the United States, Canada, Mexico, and Hong Kong. The Company leases all store premises, regional distribution facilities, some of its office space, and certain information technology and office equipment. American Eagle also has its online business. It operates in two segments: American Eagle and Aerie. The majority of its revenue comes from its primary brand, American Eagle, which offers an assortment of specialty apparel, accessories, and personal care products for women and men. Geographically, it generates the majority of its revenue from the United States.

Share on Social Networks: